Literature DB >> 2352647

Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.

C D Blaha1, A Coury, H C Fibiger, A G Phillips.   

Abstract

The effects of the neuropeptide neurotensin on dopamine release and metabolism in the posteromedial nucleus accumbens and anterior dorsomedial striatum of the anesthetized rat were investigated using in vivo chronoamperometry and intracerebral microdialysis techniques. A dose-dependent augmentation of dopamine efflux as evidenced by increases in the chronoamperometric signal was observed in the nucleus accumbens following intracerebroventricular injections of neurotensin. However, neurotensin failed to alter extracellular concentrations of dopamine in the striatum. The selective effects of neurotensin on mesolimbic dopamine neurons were confirmed using in vivo microdialysis. These results demonstrate that neurotensin can selectively enhance the release and metabolism of dopamine in neurons projecting from the ventral tegmental area to the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352647     DOI: 10.1016/0306-4522(90)90176-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine.

Authors:  C Betancur; R Cabrera; E R de Kloet; D Pélaprat; W Rostène
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

Review 2.  Development of intraoperative electrochemical detection: wireless instantaneous neurochemical concentration sensor for deep brain stimulation feedback.

Authors:  Jamie J Van Gompel; Su-Youne Chang; Stephan J Goerss; In Yong Kim; Christopher Kimble; Kevin E Bennet; Kendall H Lee
Journal:  Neurosurg Focus       Date:  2010-08       Impact factor: 4.047

3.  Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist.

Authors:  Vanessa Lopak; Suzanne Erb
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 4.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

5.  Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens.

Authors:  K Ikemoto; K Satoh; K Kitahama; M Geffard; T Maeda
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

6.  Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Authors:  C Betancur; M Canton; D Gully; G Vela; D Pélaprat; W Rostène
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

7.  The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.

Authors:  L Ferraro; T Antonelli; W T O'Connor; K Fuxe; P Soubrié; S Tanganelli
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

8.  Neurochemical heterogeneity of the primate nucleus accumbens.

Authors:  K Ikemoto; K Satoh; T Maeda; H C Fibiger
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

9.  Comparison of the locomotor-activating effects of bicuculline infusions into the preoptic area and ventral pallidum.

Authors:  Daniel S Zahm; Zachary M Schwartz; Heather N Lavezzi; Leora Yetnikoff; Kenneth P Parsley
Journal:  Brain Struct Funct       Date:  2013-02-20       Impact factor: 3.270

Review 10.  Wireless neurochemical monitoring in humans.

Authors:  Aimen Kasasbeh; Kendall Lee; Allan Bieber; Kevin Bennet; Su-Youne Chang
Journal:  Stereotact Funct Neurosurg       Date:  2013-02-27       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.